Special Research Program SFB-54: "InThro"


Thrombosis is a hallmark of life-threatening diseases, such as myocardial infarction, stroke or venous thromboembolism representing major causes of death in the western civilization. In 2014 the Special Research Program SFB-F54 (“Cellular Mediators Linking Inflammation and Thrombosis”) was launched at the Medical University Vienna financed by the Austrian Science Fund (FWF), which comprises a network of eight research groups that are focusing on molecular and cellular links between inflammation and thrombotic diseases to provide a new view of thrombosis integrating the role of inflammatory processes thereby building up new strategies for therapeutic interventions.

Our Special Research Program SFB-F54 has been extended for a second funding phase from 2018 - 2022. The project ended by 31th of July 2022.



Dr. Karin Hochrainer (Weill Cornell Medicine, NYC)


“From lipids to thrombosis: translational research targeting HDL and platelet function”


2018-09-28, 3.p.m.; Seminarroom E8, CeMM


News and recent publications


Ingrid Pabinger-Fasching


Extracellular Vesicles Linking Inflammation, Cancer and Thrombotic Risks


Disease models play a major role in Covid-19 research since they allow the study of disease mechanisms or the development of effective and safe vaccines and treatments. In the search for ever better tools, a research group led by Sylvia Knapp at..


Christoph Binder's group could show that APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans